Acurx Pharmaceuticals Inc

NAS:ACXP (USA)   Ordinary Shares
$ 2.07 +0.05 (+2.48%) 10:08 PM EST
At Loss
P/B:
0.52
Market Cap:
$ 32.62M
Enterprise V:
$ 24.36M
Volume:
28.59K
Avg Vol (2M):
87.01K
Also Trade In:
Volume:
28.59K
At Loss
Avg Vol (2M):
87.01K

Business Description

Acurx Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
ISIN : US00510M1045

Share Class Description:

ACXP: Ordinary Shares
Description
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 7.51
Interest Coverage No Debt
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 64.62
9-Day RSI 54.87
14-Day RSI 48.39
6-1 Month Momentum % -55.93
12-1 Month Momentum % -30.9

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.53
Quick Ratio 2.53
Cash Ratio 2.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.9
Name Current Vs Industry Vs History
ROE % -61.1
ROA % -178.37
ROIC % -4795.39
ROCE % -265.59